Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
-
Measles roars back in the US, topping 1,000 cases
-
Fulham boss Silva refuses to rule out Saudi switch
-
From Chicago to Chiclayo: Peruvian town hails adoptive son and pope
-
Ivorian women fight FGM with reconstructive surgery
-
Pedersen wins opening stage of Giro d'Italia in Albania
-
Stocks mixed despite hopes for US-China tariff talks
-
US, Swiss agree to speed up tariff talks
-
Trump floats cutting China tariffs to 80% ahead of trade talks
-
Pedersen wins opening stage of Giro d'Italia
-
Marc Marquez sets Le Mans lap record in French MotoGP practice
-
Jungle music: Chimp drumming reveals building blocks of human rhythm
-
Guardiola tells Man City stars to question their hunger after troubled season
-
Putin, Xi, Steven Seagal and missiles: Russia's Red Square parade
-
Trump suggests lower 80% China tariff ahead of Geneva trade talks
-
Arteta wants Arsenal to use Liverpool guard of honour as title fuel
-
Stocks lifted by hopes for US-China talks
-
Putin hails troops in Ukraine as allies attend WWII parade
-
UK, northern European nations support Ukraine 30-day ceasefire: Norway PM
-
Activists hold 'die-in' protest at Soviet monument in Warsaw
-
Trump suggests lower China tariff, says 80% 'seems right!'
-
Alonso confirms exit from Leverkusen at end of season
-
Maresca ready for Chelsea's 'huge' Newcastle test
-
Alcaraz, Sabalenka cruise to wins at the Italian Open
-
Swiss seize window of opportunity on Trump tariffs
-
Amorim admits Man Utd 'problems' despite reaching Europa League final
-
New Pope Leo XIV has mixed record on abuse: campaigners
-
Xabi Alonso confirms exit from Bayer Leverkusen at season's end
-
From blockades to ballots: Serbian students confront government
-
Kyiv's EU allies endorse tribunal to try Russian leaders
-
Two men found guilty of chopping down iconic UK tree
-
Tennis, Twitter and marinated fish: Things to know about Pope Leo
-
Liverpool's Salah voted Football Writers' Player of the Year
-
Pakistan says India has brought neighbours 'closer to major conflict'
-
Stocks lifted by hopes for US-China talks after UK deal
-
Putin hails troops fighting in Ukraine as foreign leaders attend parade
-
Howe urges Newcastle to fulfil Champions League expectation
-
Weary border residents in Indian Kashmir struggle to survive
-
Leo XIV says Church must fight 'lack of faith' in first mass as pope
-
Liverpool boss Slot fears replacing Alexander-Arnold will be a tough task
-
British Airways owner unveils big Boeing, Airbus order
-
IPL suspended for one week over India-Pakistan conflict
-
Slot says all at Liverpool sad to see Alexander-Arnold go
-
Leo XIV celebrates first mass as pope in Sistine Chapel
-
India says repulsed fresh Pakistan attacks as death toll climbs
-
Japan's Panasonic targets 10,000 job cuts worldwide
-
Putin evokes WWII victory to rally Russia behind Ukraine offensive
-
China exports beat forecasts ahead of US tariff talks
-
Leo XIV, the 'Latin Yankee', to celebrate first mass as pope
-
Most stocks lifted by hopes for US-China talks after UK deal
-
IPL suspended indefinitely over India-Pakistan conflict: reports
NYSE - LSE
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The company remains committed to its strategic growth plan, which centers on acquiring revenue-positive e-commerce websites and integrating advanced AI technology to drive expansion in the health and wellness sector.
Bionoid's proprietary AI Maverick Intel platform will play a pivotal role in the company's growth strategy. This cutting-edge AI-driven marketing system is designed to enhance customer engagement, optimize advertising efficiency, and deliver tailored user experiences. By leveraging AI Maverick Intel, Bionoid aims to maximize the potential of its e-commerce platforms and solidify its position as an innovator in the industry.
"Our vision for 2025 is focused on scaling our operations through strategic acquisitions and harnessing the power of AI technology," said Wayne Cockburn, CEO of Bionoid Pharma, Inc. "AI Maverick Intel is a cornerstone of our strategy, enabling us to deliver unparalleled customer experiences while driving sustainable growth and profitability."
Bionoid plans to expand its portfolio with high-value, revenue-generating e-commerce websites in the health and wellness sector, ensuring each acquisition aligns with its long-term objectives. The company is confident its continued focus on innovation and strategic execution will deliver strong results for its stakeholders in the coming year.
About Bionoid Pharma, Inc.
Bionoid Pharma, Inc. is a forward-thinking health and wellness company dedicated to expanding its revenue streams and brand presence through strategic acquisitions and advanced AI technology. Its proprietary AI Maverick platform supports the company's mission to deliver innovative, AI-driven solutions that foster customer loyalty, operational excellence, and sustainable growth.
Stay connected:
Website: BionoidPhama.com
OTC Markets: BINP
For further information, contact:
Wayne Cockburn, CEO
Phone: (905) 505-0770
Email: [email protected]
SOURCE: Bionoid Pharma, Inc.
O.Norris--AMWN
